Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmRNA cap binding complex binding

SRRT ZC3H18

8.29e-064242GO:0140262
GeneOntologyBiologicalProcesspyruvate transmembrane transport

SLC16A1 MPC2

2.72e-057242GO:1901475
GeneOntologyBiologicalProcesspyruvate transport

SLC16A1 MPC2

4.65e-059242GO:0006848
GeneOntologyBiologicalProcessmitochondrial transport

MPC2 SLC25A31 BCL2L1 CPT1B

8.62e-05205244GO:0006839
GeneOntologyBiologicalProcessnegative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway

SLC25A31 BCL2L1

1.35e-0415242GO:1901029
GeneOntologyBiologicalProcessmitochondrial transmembrane transport

MPC2 SLC25A31 CPT1B

2.47e-04106243GO:1990542
GeneOntologyBiologicalProcessnegative regulation of mitochondrial membrane permeability

SLC25A31 BCL2L1

3.23e-0423242GO:0035795
GeneOntologyBiologicalProcessregulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway

SLC25A31 BCL2L1

3.53e-0424242GO:1901028
GeneOntologyBiologicalProcessnegative regulation of membrane permeability

SLC25A31 BCL2L1

4.15e-0426242GO:1905709
GeneOntologyBiologicalProcessalditol metabolic process

FKRP MYOF

4.15e-0426242GO:0019400
DomainRCC1

IBTK RCC1L

2.96e-0420242PF00415
DomainRCC1_3

IBTK RCC1L

3.27e-0421242PS50012
DomainRCC1_1

IBTK RCC1L

3.27e-0421242PS00625
DomainRCC1_2

IBTK RCC1L

3.27e-0421242PS00626
DomainReg_chr_condens

IBTK RCC1L

3.60e-0422242IPR000408
Domain-

IBTK RCC1L

3.60e-04222422.130.10.30
DomainRCC1/BLIP-II

IBTK RCC1L

3.94e-0423242IPR009091
DomainBTB

KCNS2 IBTK

2.22e-02180242SM00225
Pubmed

Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate.

SRRT ZC3H18

1.37e-06324228297668
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

SLC16A1 LGR4 SRRT ZC3H18

1.07e-0520224424639526
Pubmed

The nuclear cap-binding complex interacts with the U4/U6·U5 tri-snRNP and promotes spliceosome assembly in mammalian cells.

SRRT ZC3H18

3.00e-051224223793891
Pubmed

Embryonic cardiomyocytes can orchestrate various cell protective mechanisms to survive mitochondrial stress.

BCL2L1 CHAC1

1.25e-042424227106802
Pubmed

The interactome of intact mitochondria by cross-linking mass spectrometry provides evidence for coexisting respiratory supercomplexes.

SLC16A1 MPC2 RCC1L CPT1B

1.28e-0438224429222160
Pubmed

Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.

SRRT FBXO31 MPC2 RCC1L SLC25A31

1.39e-0475024511230166
Pubmed

Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.

HELZ2 MYOF GANAB

1.55e-0415224316009940
Pubmed

Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria.

INPP5E MPC2 BCL2L1 CPT1B

4.84e-0454224414651853
Pubmed

A mitochondrial protein compendium elucidates complex I disease biology.

SLC16A1 MPC2 RCC1L SLC25A31 CPT1B

6.46e-04104724518614015
Cytoband16q24.2

FBXO31 ZC3H18

2.04e-051324216q24.2
CytobandEnsembl 112 genes in cytogenetic band chr16q24

FBXO31 ZC3H18

2.30e-03136242chr16q24
Drugcelecoxib; Up 200; 10uM; MCF7; HT_HG-U133A_EA

SRRT BCL2L1 CHAC1 CPT1B

4.29e-05189244922_UP
DrugNitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A

SRRT BCL2L1 CHAC1 GANAB

4.47e-051912446721_DN
Drug2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A

SRRT BCL2L1 CHAC1 CPT1B

4.95e-051962441639_UP
DrugDydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A

MYOF LEPROT BCL2L1 CPT1B

5.04e-051972444836_DN
DrugNaloxone hydrochloride [357-08-4]; Up 200; 11uM; HL60; HG-U133A

LGR4 SRRT MYOF CHAC1

5.14e-051982442006_UP
DrugGW 6471

BCL2L1 CPT1B

1.27e-0416242ctd:C449302
DrugBortezomib

LGR4 SRRT IBTK BCL2L1 CHAC1 GANAB

1.86e-04838246ctd:D000069286
DrugAD 198

BCL2L1 CPT1B

2.00e-0420242CID000127201
Drugacetoacetate

SLC16A1 C2 CPT1B

2.80e-04122243CID000000096
DrugPOCA

C2 CPT1B

3.41e-0426242CID000054217
Drugalpha-cyano-4-hydroxycinnamate

SLC16A1 C2

5.51e-0433242CID000002102
DrugVerteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A

SLC16A1 LGR4 GANAB

5.64e-041552436817_DN
DrugVerteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A

SLC16A1 LGR4 GANAB

6.30e-041612433556_DN
DrugCETTD

C2 CPT1B

6.93e-0437242CID000150912
Drugisethionate

C2 CPT1B

7.31e-0438242CID000007866
Drugpropionyl-L-carnitine

C2 CPT1B

7.31e-0438242CID000107738
Drugfelodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA

SLC16A1 CHAC1 CPT1B

7.38e-04170243965_UP
DrugCycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A

SLC16A1 LGR4 CHAC1

7.50e-041712432723_DN
DrugBilirubin

LEPROT BCL2L1 CHAC1

8.16e-04176243ctd:D001663
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

MYOF INPP5E BCL2L1

8.43e-041782434184_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

IBTK INPP5E BCL2L1

8.43e-041782437245_DN
DrugPergolide mesylate [66104-23-2]; Down 200; 9.8uM; HL60; HT_HG-U133A

SLC16A1 LGR4 CHAC1

8.84e-041812432403_DN
DrugDihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; HL60; HT_HG-U133A

SLC16A1 LGR4 CHAC1

8.84e-041812432136_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

MYOF INPP5E BCL2L1

8.99e-041822435802_DN
DrugNocodazole [31430-18-9]; Down 200; 13.2uM; HL60; HG-U133A

SLC16A1 LGR4 CHAC1

9.27e-041842431393_DN
DrugClonidine hydrochloride [4205-91-8]; Down 200; 15uM; HL60; HG-U133A

SLC16A1 LGR4 CHAC1

9.57e-041862431555_DN
Druggeldanamycin; Down 200; 1uM; HL60; HT_HG-U133A

SLC16A1 MYOF CHAC1

9.87e-041882436187_DN
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

SLC16A1 LGR4 CHAC1

9.87e-041882431177_DN
DrugTrifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A

MYOF BCL2L1 CHAC1

9.87e-041882433559_UP
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

MYOF BCL2L1 CHAC1

1.00e-031892436954_UP
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

MYOF CHAC1 CPT1B

1.00e-031892435578_DN
DrugFluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A

SRRT BCL2L1 CPT1B

1.02e-031902434314_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

SRRT INPP5E BCL2L1

1.02e-031902436709_DN
DrugAmbroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; PC3; HT_HG-U133A

SRRT BCL2L1 GANAB

1.02e-031902436719_DN
DrugPaclitaxel [33069-62-4]; Down 200; 4.6uM; PC3; HT_HG-U133A

SRRT BCL2L1 GANAB

1.03e-031912436720_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA

MYOF INPP5E CHAC1

1.03e-03191243998_DN
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A

SLC16A1 SRRT CHAC1

1.03e-031912436998_DN
Drug5114445; Up 200; 10uM; MCF7; HT_HG-U133A_EA

BCL2L1 CHAC1 CPT1B

1.05e-03192243901_UP
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A

MYOF LEPROT CHAC1

1.05e-031922432703_DN
Diseasevital capacity

LGR4 LEPROT SLC25A31 BCL2L1 CHAC1

2.29e-031236235EFO_0004312
DiseaseAlloxan Diabetes

BCL2L1 CPT1B

3.19e-03108232C0002152
DiseaseStreptozotocin Diabetes

BCL2L1 CPT1B

3.19e-03108232C0038433
DiseaseDiabetes Mellitus, Experimental

BCL2L1 CPT1B

3.19e-03108232C0011853
Diseasewhite matter integrity

GAL3ST1 C2

4.59e-03130232EFO_0004641

Protein segments in the cluster

PeptideGeneStartEntry
FRDGVNWGRIVAFFS

BCL2L1

131

Q07817
REFFGGLDPFSFEFW

DNAJB8

101

Q8NHS0
ARADRVFVWGFSFSG

RCC1L

56

Q96I51
FFVGAAGASQLFRIW

MPC2

101

O95563
QVFFGIFGWRGSFLI

SLC16A1

166

P53985
FFLIFGRGDDFSWEQ

LEPROT

116

O15243
TTRFDEVFWFGDFNF

INPP5E

466

Q9NRR6
EVFWFGDFNFRLSGG

INPP5E

471

Q9NRR6
LFVTQDGEGFRGRWF

IBTK

451

Q9P2D0
ERRFRFFQVGLVSWG

C2

686

P06681
GVFILFDEDRFGFVW

FBXO31

486

Q5XUX0
GFFGRWELQIFFFVT

OR4L1

16

Q8NH43
RFEIVEHFGIAWFTF

KCNS2

226

Q9ULS6
FLDAVSWGRFAEFGI

LGR4

596

Q9BXB1
FNASFWRKVEAFGRE

GAL3ST1

311

Q99999
VRIPREQGFFSFWRG

SLC25A31

71

Q9H0C2
FVRGYSRRFWQGDTF

CHAC1

56

Q9BUX1
WLAFESRAFRGEQFV

CRYBB3

66

P26998
GFVWEKAVEGDFFRV

FKRP

391

Q9H9S5
FGTFEQWVVFDFGRR

HELZ2

246

Q9BYK8
IFSTGVWVTGIFFFR

CPT1B

111

Q92523
ARAFFAGSQRFGAVW

GANAB

601

Q14697
FFRRGWVTFDRSVNI

SRRT

461

Q9BXP5
IERFWRGGQYENFRV

ZC3H18

376

Q86VM9
RSLDGEGNFNWRFVF

MYOF

1836

Q9NZM1